Literature DB >> 6467682

Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases.

M Manns, K H Meyer zum Büschenfelde, J Slusarczyk, H P Dienes.   

Abstract

A radioimmunoassay (RIA) was developed for the detection of liver-kidney microsomal (LKM) autoantibodies. These were detected in four of 62 patients with HBsAg negative chronic active hepatitis (CAH) and in one patient with mixed connective tissue disease (MCTD). LKM antibodies were not detected in other hepatic and non-hepatic diseases. Other autoantibodies, especially anti-mitochondrial ones, do not react in this assay system. Sera positive for LKM antibodies by RIA showed a cytoplasmic staining of hepatocytes and proximal renal tubules by immunofluorescence. The LKM antigen was detected by RIA in microsomes prepared from rat liver, kidney, stomach, heart, lung, and skeletal muscle. It was destroyed after treatment with trypsin and chymotrypsin, but preserved after treatment with RNAase, DNAase and neuraminidase. Upon centrifugation of purified rat liver microsomes in CsCl gradient, LKM reactivity was detected at a density of 1.20 g/ml. In addition, the M2 antigen of the inner mitochondrial membrane specific for primary biliary cirrhosis (PBC) was localized at 1.28 g/ml in these density gradient fractions. The LKM antigen could not be solubilized. The presence of LKM antibodies characterizes a distinct subgroup of HBsAg negative CAH; they do not occur in PBC.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467682      PMCID: PMC1536275     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  The immunoelectron-microscopical demonstration of antibodies against endoplasmic reticulum (microsomes) in chronic aggressive hepatitis and liver cirrhosis.

Authors:  W Storch; L Cossel; R Dargel
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  Characterization of the microsomal antigen related to a subclass of active chronic hepatitis.

Authors:  M Rizzetto; F B Bianchi; D Doniach
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

4.  Microsomal antibodies in active chronic hepatitis and other disorders.

Authors:  M Rizzetto; G Swana; D Doniach
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

5.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

6.  Treatment of chronic active hepatitis.

Authors:  S W Schalm
Journal:  Liver       Date:  1982-06

7.  Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome.

Authors:  T J Sayers; T Binder; P A Berg
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

8.  Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay.

Authors:  M Manns; K H Meyer zum Büschenfelde; T H Hütteroth; G Hess
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent.

Authors:  O Crivelli; C Lavarini; E Chiaberge; A Amoroso; P Farci; F Negro; M Rizzetto
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

10.  Hepatic disorders associated with liver-kidney microsomal antibodies.

Authors:  M G Smith; R Williams; G Walker; M Rizzetto; D Doniach
Journal:  Br Med J       Date:  1974-04-13
View more
  9 in total

Review 1.  Cytochrome P450 enzymes as human autoantigens.

Authors:  M P Manns
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  Nature of autoantigens and autoantibodies in autoimmune hepatitis.

Authors:  M P Manns; K H Meyer zum Büschenfelde
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

Authors:  M P Manns; E F Johnson; K J Griffin; E M Tan; K F Sullivan
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

4.  LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

Authors:  M P Manns; K J Griffin; K F Sullivan; E F Johnson
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

5.  Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis.

Authors:  H Löhr; M Manns; A Kyriatsoulis; A W Lohse; C Trautwein; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

6.  Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis.

Authors:  K H Meyer zum Büschenfelde; U Treichel; H Löhr; B Fleischer; T Poralla
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia.

Authors:  M Peters; M Trippler; H Löhr; W Gödderz; W Herr; S Störkel; K H Meyer zum Büschenfelde; G Gerken
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

8.  Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue.

Authors:  A Kyriatsoulis; M Manns; G Gerken; A W Lohse; W Ballhausen; K Reske; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

9.  Hepatocellular carcinoma in patients with autoimmune hepatitis.

Authors:  Andreas Teufel; Arndt Weinmann; Catherine Centner; Anja Piendl; Ansgar W Lohse; Peter R Galle; Stephan Kanzler
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.